Kevin Mannix | Senior Vice President of Investor Relations |
Kare Schultz | President and Chief Executive Officer |
Michael McClellan | Executive Vice President & Chief Financial Officer |
Brendan O'Grady | Executive Vice President of North America Commercial |
Elliot Wilbur | Raymond James |
Ken Cacciatore | Cowen And Company |
Esther Rajavelu | Oppenheimer & Co. |
Gregg Gilbert | SunTrust Robinson Humphry |
David Risinger | Morgan Stanley |
Ronny Gal | Sanford C. Bernstein & Co. |
Eason Lee | SVB Leerink |
Dana Flanders | Guggenheim |
Christopher Schott | JPMorgan |
Akash Tewari | Wolfe Research |
Jason Gerberry | Bank of America Merrill Lynch |
David Amsellem | Piper Jaffray |
Umer Raffat | Evercore ISI |
Gary Nachman | BMO Capital Markets |
Ladies and gentlemen, thank you for standing by, and welcome to the Teva Pharmaceuticals Third Quarter 2019 Financial Results Conference Call. [Operator Instructions] I must advise you, the conference is being recorded today.
I would now like to hand the conference over to your first speaker today, Kevin Mannix. Please go ahead.
Thank you, Laura.